Joint linkage and association analysis with exome sequence data implicates SLC25A40 in hypertriglyceridemia

American Journal of Human Genetics

Volumn 93, Issue 6, 2013, Pages 1035-1045

  Rosenthal, Elisabeth A ^a   Ranchalis, Jane ^a   Crosslin, David R ^b   Burt, Amber ^a   Brunzell, John D ^b   Motulsky, Arno G ^a,b   Nickerson, Deborah A ^b   Wijsman, Ellen M ^a,b   Jarvik, Gail P ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; SLC25A40 PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CHROMOSOME 17; CHROMOSOME 7; EXOME; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84890308141     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2013.10.019     Document Type: Article

References (67)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
2. J.E. Hokanson, and M.A. Austin Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies J. Cardiovasc. Risk 3 1996 213 219
3. A. Patel, F. Barzi, K. Jamrozik, T.H. Lam, H. Ueshima, G. Whitlock, M. Woodward Asia Pacific Cohort Studies Collaboration Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region Circulation 110 2004 2678 2686
4. A. Tirosh, A. Rudich, T. Shochat, D. Tekes-Manova, E. Israeli, Y. Henkin, I. Kochba, and I. Shai Changes in triglyceride levels and risk for coronary heart disease in young men Ann. Intern. Med. 147 2007 377 385
5. M. Miller, C.P. Cannon, S.A. Murphy, J. Qin, K.K. Ray, E. Braunwald PROVE IT-TIMI 22 Investigators Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial J. Am. Coll. Cardiol. 51 2008 724 730
6. P. Kohli, and C.P. Cannon Triglycerides: how much credit do they deserve? Med. Clin. North Am. 96 2012 39 55
7. M. Miller, N.J. Stone, C. Ballantyne, V. Bittner, M.H. Criqui, H.N. Ginsberg, A.C. Goldberg, W.J. Howard, M.S. Jacobson, P.M. Kris-Etherton American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism Council on Arteriosclerosis, Thrombosis and Vascular Biology Council on Cardiovascular Nursing Council on the Kidney in Cardiovascular Disease Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association Circulation 123 2011 2292 2333
8. B.F. Voight, G.M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, M.K. Jensen, G. Hindy, H. Hólm, E.L. Ding, and T. Johnson Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study Lancet 380 2012 572 580
9. G.G. Schwartz, A.G. Olsson, M. Abt, C.M. Ballantyne, P.J. Barter, J. Brumm, B.R. Chaitman, I.M. Holme, D. Kallend, L.A. Leiter dal-OUTCOMES Investigators Effects of dalcetrapib in patients with a recent acute coronary syndrome N. Engl. J. Med. 367 2012 2089 2099
10. N. Sarwar, M.S. Sandhu, S.L. Ricketts, A.S. Butterworth, E. Di Angelantonio, S.M. Boekholdt, W. Ouwehand, H. Watkins, N.J. Samani, D. Saleheen Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies Lancet 375 2010 1634 1639
11. M. Lee, J.L. Saver, A. Towfighi, J. Chow, and B. Ovbiagele Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis Atherosclerosis 217 2011 492 498
12. E. Bruckert, J. Labreuche, D. Deplanque, P.J. Touboul, and P. Amarenco Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: A systematic review and meta-analysis J. Cardiovasc. Pharmacol. 57 2011 267 272
13. A.S. Wierzbicki, T.C. Hardman, and A. Viljoen New lipid-lowering drugs: An update Int. J. Clin. Pract. 66 2012 270 280
14. L.A. Pennacchio, M. Olivier, J.A. Hubacek, R.M. Krauss, E.M. Rubin, and J.C. Cohen Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels Hum. Mol. Genet. 11 2002 3031 3038
15. P.J. Talmud, E. Hawe, S. Martin, M. Olivier, G.J. Miller, E.M. Rubin, L.A. Pennacchio, and S.E. Humphries Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides Hum. Mol. Genet. 11 2002 3039 3046
16. S. Romeo, L.A. Pennacchio, Y. Fu, E. Boerwinkle, A. Tybjaerg-Hansen, H.H. Hobbs, and J.C. Cohen Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL Nat. Genet. 39 2007 513 516
17. S. Kathiresan, O. Melander, C. Guiducci, A. Surti, N.P. Burtt, M.J. Rieder, G.M. Cooper, C. Roos, B.F. Voight, and A.S. Havulinna Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans Nat. Genet. 40 2008 189 197
18. J.S. Kooner, J.C. Chambers, C.A. Aguilar-Salinas, D.A. Hinds, C.L. Hyde, G.R. Warnes, F.J. Gómez Pérez, K.A. Frazer, P. Elliott, and J. Scott Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides Nat. Genet. 40 2008 149 151
19. T.M. Teslovich, K. Musunuru, A.V. Smith, A.C. Edmondson, I.M. Stylianou, M. Koseki, J.P. Pirruccello, S. Ripatti, D.I. Chasman, and C.J. Willer Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
20. S.K. Nilsson, J. Heeren, G. Olivecrona, and M. Merkel Apolipoprotein A-V; a potent triglyceride reducer Atherosclerosis 219 2011 15 21
21. C.T. Johansen, S. Kathiresan, and R.A. Hegele Genetic determinants of plasma triglycerides J. Lipid Res. 52 2011 189 206
22. N. Baroukh, E. Bauge, J. Akiyama, J. Chang, V. Afzal, J.C. Fruchart, E.M. Rubin, J. Fruchart-Najib, and L.A. Pennacchio Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice Arterioscler. Thromb. Vasc. Biol. 24 2004 1297 1302
23. Y. Ito, N. Azrolan, A. O'Connell, A. Walsh, and J.L. Breslow Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice Science 249 1990 790 793
24. L.A. Pennacchio, M. Olivier, J.A. Hubacek, J.C. Cohen, D.R. Cox, J.C. Fruchart, R.M. Krauss, and E.M. Rubin An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing Science 294 2001 169 173
25. N. Maeda, H. Li, D. Lee, P. Oliver, S.H. Quarfordt, and J. Osada Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia J. Biol. Chem. 269 1994 23610 23616
26. G.T. Russo, J.B. Meigs, L.A. Cupples, S. Demissie, J.D. Otvos, P.W. Wilson, C. Lahoz, D. Cucinotta, P. Couture, and T. Mallory Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: The Framingham offspring study Atherosclerosis 158 2001 173 181
27. O. Olivieri, A. Bassi, C. Stranieri, E. Trabetti, N. Martinelli, F. Pizzolo, D. Girelli, S. Friso, P.F. Pignatti, and R. Corrocher Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease J. Lipid Res. 44 2003 2374 2381
28. S.F. Vaessen, F.G. Schaap, J.A. Kuivenhoven, A.K. Groen, B.A. Hutten, S.M. Boekholdt, H. Hattori, M.S. Sandhu, S.A. Bingham, and R. Luben Apolipoprotein A-V, triglycerides and risk of coronary artery disease: The prospective Epic-Norfolk Population Study J. Lipid Res. 47 2006 2064 2070
29. N. Bi, S.K. Yan, G.P. Li, Z.N. Yin, and B.S. Chen A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese Mol. Genet. Metab. 83 2004 280 286
30. J. Dallongeville, D. Cottel, M. Montaye, V. Codron, P. Amouyel, and N. Helbecque Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men Int. J. Cardiol. 106 2006 152 156
31. E.M. Wijsman The role of large pedigrees in an era of high-throughput sequencing Hum. Genet. 131 2012 1555 1563
32. G.P. Jarvik, J.D. Brunzell, M.A. Austin, R.M. Krauss, A.G. Motulsky, and E. Wijsman Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype Arterioscler. Thromb. 14 1994 1687 1694
33. J.L. Goldstein, H.G. Schrott, W.R. Hazzard, E.L. Bierman, and A.G. Motulsky Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia J. Clin. Invest. 52 1973 1544 1568
34. J.L. Goldstein, S.E. Dana, G.Y. Brunschede, and M.S. Brown Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor Proc. Natl. Acad. Sci. USA 72 1975 1092 1096
35. J.L. Breslow Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility Annu. Rev. Genet. 34 2000 233 254
36. E.S. Ford, C. Li, G. Zhao, W.S. Pearson, and A.H. Mokdad Hypertriglyceridemia and its pharmacologic treatment among US adults Arch. Intern. Med. 169 2009 572 578
37. M.A. Austin, B. McKnight, K.L. Edwards, C.M. Bradley, M.J. McNeely, B.M. Psaty, J.D. Brunzell, and A.G. Motulsky Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study Circulation 101 2000 2777 2782
38. A. Chait, and J.D. Brunzell Chylomicronemia syndrome Adv. Intern. Med. 37 1992 249 273
39. G.R. Warnick Enzymatic methods for quantification of lipoprotein lipids Methods Enzymol. 129 1986 101 123
40. US Dept of Health and Human Services The Lipid Research Clinics' Population Studies Data Book Volume 1 1980 National Institutes of Health Washington, DC
41. E.A. Rosenthal, J. Ronald, J. Rothstein, R. Rajagopalan, J. Ranchalis, G. Wolfbauer, J.J. Albers, J.D. Brunzell, A.G. Motulsky, and M.J. Rieder Linkage and association of phospholipid transfer protein activity to LASS4 J. Lipid Res. 52 2011 1837 1846
42. E.M. Wijsman, J.H. Rothstein, R.P. Igo Jr., J.D. Brunzell, A.G. Motulsky, and G.P. Jarvik Linkage and association analyses identify a candidate region for apoB level on chromosome 4q32.3 in FCHL families Hum. Genet. 127 2010 705 719
43. B.J. Keating, S. Tischfield, S.S. Murray, T. Bhangale, T.S. Price, J.T. Glessner, L. Galver, J.C. Barrett, S.F.A. Grant, and D.N. Farlow Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies PLoS ONE 3 2008 e3583
44. S.B. Ng, E.H. Turner, P.D. Robertson, S.D. Flygare, A.W. Bigham, C. Lee, T. Shaffer, M. Wong, A. Bhattacharjee, and E.E. Eichler Targeted capture and massively parallel sequencing of 12 human exomes Nature 461 2009 272 276
45. F.M. De La Vega, D. Dailey, J. Ziegle, J. Williams, D. Madden, and D.A. Gilbert New generation pharmacogenomic tools: A SNP linkage disequilibrium Map, validated SNP assay resource, and high-throughput instrumentation system for large-scale genetic studies Biotechniques Suppl 2002 48 50 52, 54
46. C.H. Lin, J.M. Yeakley, T.K. McDaniel, and R. Shen Medium- to high-throughput SNP genotyping using VeraCode microbeads Methods Mol. Biol. 496 2009 129 142
47. S.C. Heath Markov chain Monte Carlo segregation and linkage analysis for oligogenic models Am. J. Hum. Genet. 61 1997 748 760
48. F. Gagnon, G.P. Jarvik, M.D. Badzioch, A.G. Motulsky, J.D. Brunzell, and E.M. Wijsman Genome scan for quantitative trait loci influencing HDL levels: evidence for multilocus inheritance in familial combined hyperlipidemia Hum. Genet. 117 2005 494 505
49. Yu, D. (2003). Testing the robustness of Markov chain Monte Carlo segregation and linkage analysis when normality assumptions are violated. PhD thesis, University of Washington, Seattle, WA.
50. E.M. Wijsman, E.W. Daw, C.E. Yu, H. Payami, E.J. Steinbart, D. Nochlin, E.M. Conlon, T.D. Bird, and G.D. Schellenberg Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2 Am. J. Hum. Genet. 75 2004 398 409
51. F. Gagnon, G.P. Jarvik, A.G. Motulsky, S.S. Deeb, J.D. Brunzell, and E.M. Wijsman Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment Hum. Genet. 113 2003 522 533
52. I.J. Goldberg, R.H. Eckel, and R. McPherson Triglycerides and heart disease: still a hypothesis? Arterioscler. Thromb. Vasc. Biol. 31 2011 1716 1725
53. A.D. Johnson, R.E. Handsaker, S.L. Pulit, M.M. Nizzari, C.J. O'Donnell, and P.I. de Bakker SNAP: A web-based tool for identification and annotation of proxy SNPs using HapMap Bioinformatics 24 2008 2938 2939
54. G.R. Abecasis, D. Altshuler, A. Auton, L.D. Brooks, R.M. Durbin, R.A. Gibbs, M.E. Hurles, G.A. McVean 1000 Genomes Project Consortium A map of human genome variation from population-scale sequencing Nature 467 2010 1061 1073
55. S.T. Sherry, M.H. Ward, M. Kholodov, J. Baker, L. Phan, E.M. Smigielski, and K. Sirotkin dbSNP: The NCBI database of genetic variation Nucleic Acids Res. 29 2001 308 311
56. G.M. Cooper, E.A. Stone, G. Asimenos, E.D. Green, S. Batzoglou, A. Sidow NISC Comparative Sequencing Program Distribution and intensity of constraint in mammalian genomic sequence Genome Res. 15 2005 901 913
57. L. Almasy, and J. Blangero Multipoint quantitative-trait linkage analysis in general pedigrees Am. J. Hum. Genet. 62 1998 1198 1211
58. W.J. Kent, C.W. Sugnet, T.S. Furey, K.M. Roskin, T.H. Pringle, A.M. Zahler, and D. Haussler The human genome browser at UCSC Genome Res. 12 2002 996 1006
59. E.V. Davydov, D.L. Goode, M. Sirota, G.M. Cooper, A. Sidow, and S. Batzoglou Identifying a high fraction of the human genome to be under selective constraint using GERP++ PLoS Comput. Biol. 6 2010 e1001025
60. I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, A.S. Kondrashov, and S.R. Sunyaev A method and server for predicting damaging missense mutations Nat. Methods 7 2010 248 249
61. D.J. Pagliarini, S.E. Calvo, B. Chang, S.A. Sheth, S.B. Vafai, S.E. Ong, G.A. Walford, C. Sugiana, A. Boneh, and W.K. Chen A mitochondrial protein compendium elucidates complex I disease biology Cell 134 2008 112 123
62. J.U. Pontius, L. Wagner, and G.D. Schuler UniGene: A unified view of the transcriptome J. McEntyre, J. Ostell, The NCBI Handbook 2003 National Center for Biotechnology Information Bethesda, MD
63. A. Siepel, G. Bejerano, J.S. Pedersen, A.S. Hinrichs, M. Hou, K. Rosenbloom, H. Clawson, J. Spieth, L.W. Hillier, and S. Richards Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes Genome Res. 15 2005 1034 1050
64. R. Grantham Amino acid difference formula to help explain protein evolution Science 185 1974 862 864
65. P.S. Kim, and R.L. Baldwin Specific intermediates in the folding reactions of small proteins and the mechanism of protein folding Annu. Rev. Biochem. 51 1982 459 489
66. E.M. Blackwood, and R.N. Eisenman Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc Science 251 1991 1211 1217
67. L. Kretzner, E.M. Blackwood, and R.N. Eisenman Myc and Max proteins possess distinct transcriptional activities Nature 359 1992 426 429